Wednesday, January 10, 2024 10:34:31 AM
Right then Duffy should contact Braverman for taking all the credit. This from linkedin why did Duffy not have all this in his Linkedin history. Really Duffy listed the failed Aegea Inc. and Currency Tracking Technologies which never even got started. LOLOLOL
So why would Duffy list those failures but not list being the founder of WEIT. RHETORICAL because he wasn't the founder of White Eagle International Technologies. Prove something different
You have proved what a HONORLESS LIAR you are by welching on our bet.
Andrew Braverman Managing Director at Sharp Capital Partners
Founder, President and CEOFounder, President and CEO
Medasorb TechnologiesMedasorb Technologies
Jan 1996 - Jul 2003 · 7 yrs 7 mosJan 1996 - Jul 2003 · 7 yrs 7 mos
NEW YORK, NYNEW YORK, NY
Directed efforts to commercialize polymer technology worldwide for use in the medical field for a company that has gone public and now trades under the symbol CTSO. Led negotiations of all domestic/international licensing and joint venture agreements to secure and protect intellectual property portfolio. Recruited and hired world-class team of scientists and business leaders. Secured funding and oversaw product and go-to-market strategies.
Built a staff to over 100 professionals, raised $65 million in working capital from private and institutional investors; successfully secured $2 million NIH Grant.
Secured licensing contract with Fresenius Medical Care, the largest dialysis provider in the world.
Expanded technology into additional markets for ESRD, SEPSIS and cardiopulmonary bypass.
Successfully oversaw 510k and PMA processes to support FDA and CE approvals.
Built and staffed multiple R&D laboratories and pilot plant to produce resins and support 10,000 patients. Spearheaded implementation of GMP (Good Manufacturing Practices) and pursuit of ISO 9001 registration.
Attracted the premier names of the scientific and medical world, representing notable thought leaders to fill positions on medical and scientific advisory boards. Credited for securing over 25 patents worldwide.Directed efforts to commercialize polymer technology worldwide for use in the medical field for a company that has gone public and now trades under the symbol CTSO. Led negotiations of all domestic/international licensing and joint venture agreements to secure and protect intellectual property portfolio. Recruited and hired world-class team of scientists and business leaders. Secured funding and oversaw product and go-to-market strategies. Built a staff to over 100 professionals, raised $65 million in working capital from private and institutional investors; successfully secured $2 million NIH Grant. Secured licensing contract with Fresenius Medical Care, the largest dialysis provider in the world. Expanded technology into additional markets for ESRD, SEPSIS and cardiopulmonary bypass. Successfully oversaw 510k and PMA processes to support FDA and CE approvals. Built and staffed multiple R&D laboratories and pilot plant to produce resins and support 10,000 patients. Spearheaded implementation of GMP (Good Manufacturing Practices) and pursuit of ISO 9001 registration. Attracted the premier names of the scientific and medical world, representing notable thought leaders to fill positions on medical and scientific advisory boards. Credited for securing over 25 patents worldwide.
Managing DirectorManaging Director
WHITE EAGLE INTERNATIONAL TECHNOLOGIESWHITE EAGLE INTERNATIONAL TECHNOLOGIES
Jan 1993 - Jan 1996 · 3 yrs 1 moJan 1993 - Jan 1996 · 3 yrs 1 mo
NEW YORK, NYNEW YORK, NY
Seized entrepreneurial opportunity to secure licenses for Russian medical/scientific technologies and launch commercialization efforts in the United States. Hired delegation of scientists to travel to Russia and identify technologies for potential U.S. commercialization. Successfully negotiated exclusive agreements with eminent Russian scientists. Coordinated patenting of various technologies with patent counsel, and Russian and American scientists.
Managed 15 simultaneous projects in ceramic coatings, bioremediation, agricultural products and polymeric resins.Raised over $5 million in capital from private investors; worked with Fortune 500 companies and government agencies that included DuPont, GE, 3M, NASA, DOD, and DOE, resulting in successful R&D joint ventures that saved company tens of millions in field study costs, and expedited time-to-market.
Worked directly with Russian Secretary of Science and Technology to initiate first government-sanctioned technology-transfer fund. Appeared on nationally televised documentary on technology transfer in Uzbekistan at the invitation of the Uzbekistan government.Established and managed relationships with scientific advisory boards at six major universities in the United States.
https://www.linkedin.com/in/andrew-braverman-5365aa4/
Keith Duffy
ExperienceExperience
Xeriant, Inc. logo
CEOCEO
Xeriant, Inc.Xeriant, Inc.
Oct 2018 - Present · 5 yrs 4 mosOct 2018 - Present · 5 yrs 4 mos
Boca Raton, Florida, United StatesBoca Raton, Florida, United States
Xeriant is a technology holding company focused on acquiring, developing and commercializing revolutionary, eco-friendly technologies with applications in aerospace, including innovative aircraft concepts targeting emerging opportunities with the aviation industry.Xeriant is a technology holding company focused on acquiring, developing and commercializing revolutionary, eco-friendly technologies with applications in aerospace, including innovative aircraft concepts targeting emerging opportunities with the aviation industry.…see more
CEOCEO
Currency Tracking TechnologiesCurrency Tracking Technologies
Jan 2017 - Present · 7 yrs 1 moJan 2017 - Present · 7 yrs 1 mo
Boynton Beach, FLBoynton Beach, FL
Currency Tracking Technologies develops proprietary software applications and systems for recording and managing information on U.S. currency to enhance the capabilities of law enforcement agencies and the intelligence community in detecting or solving crime.Currency Tracking Technologies develops proprietary software applications and systems for recording and managing information on U.S. currency to enhance the capabilities of law enforcement agencies and the intelligence community in detecting or solving crime.…see more
President/CEOPresident/CEO
AEGEA Entertainment, LLCAEGEA Entertainment, LLC
Jan 2012 - Present · 12 yrs 1 moJan 2012 - Present · 12 yrs 1 mo
North Palm Beach, FLNorth Palm Beach, FL
AEGEA is a planned city of entertainment and the arts in Florida.
https://www.linkedin.com/in/keith-duffy-4002ab1a/
So why would Duffy list those failures but not list being the founder of WEIT. RHETORICAL because he wasn't the founder of White Eagle International Technologies. Prove something different
You have proved what a HONORLESS LIAR you are by welching on our bet.
Andrew Braverman Managing Director at Sharp Capital Partners
Founder, President and CEOFounder, President and CEO
Medasorb TechnologiesMedasorb Technologies
Jan 1996 - Jul 2003 · 7 yrs 7 mosJan 1996 - Jul 2003 · 7 yrs 7 mos
NEW YORK, NYNEW YORK, NY
Directed efforts to commercialize polymer technology worldwide for use in the medical field for a company that has gone public and now trades under the symbol CTSO. Led negotiations of all domestic/international licensing and joint venture agreements to secure and protect intellectual property portfolio. Recruited and hired world-class team of scientists and business leaders. Secured funding and oversaw product and go-to-market strategies.
Built a staff to over 100 professionals, raised $65 million in working capital from private and institutional investors; successfully secured $2 million NIH Grant.
Secured licensing contract with Fresenius Medical Care, the largest dialysis provider in the world.
Expanded technology into additional markets for ESRD, SEPSIS and cardiopulmonary bypass.
Successfully oversaw 510k and PMA processes to support FDA and CE approvals.
Built and staffed multiple R&D laboratories and pilot plant to produce resins and support 10,000 patients. Spearheaded implementation of GMP (Good Manufacturing Practices) and pursuit of ISO 9001 registration.
Attracted the premier names of the scientific and medical world, representing notable thought leaders to fill positions on medical and scientific advisory boards. Credited for securing over 25 patents worldwide.Directed efforts to commercialize polymer technology worldwide for use in the medical field for a company that has gone public and now trades under the symbol CTSO. Led negotiations of all domestic/international licensing and joint venture agreements to secure and protect intellectual property portfolio. Recruited and hired world-class team of scientists and business leaders. Secured funding and oversaw product and go-to-market strategies. Built a staff to over 100 professionals, raised $65 million in working capital from private and institutional investors; successfully secured $2 million NIH Grant. Secured licensing contract with Fresenius Medical Care, the largest dialysis provider in the world. Expanded technology into additional markets for ESRD, SEPSIS and cardiopulmonary bypass. Successfully oversaw 510k and PMA processes to support FDA and CE approvals. Built and staffed multiple R&D laboratories and pilot plant to produce resins and support 10,000 patients. Spearheaded implementation of GMP (Good Manufacturing Practices) and pursuit of ISO 9001 registration. Attracted the premier names of the scientific and medical world, representing notable thought leaders to fill positions on medical and scientific advisory boards. Credited for securing over 25 patents worldwide.
Managing DirectorManaging Director
WHITE EAGLE INTERNATIONAL TECHNOLOGIESWHITE EAGLE INTERNATIONAL TECHNOLOGIES
Jan 1993 - Jan 1996 · 3 yrs 1 moJan 1993 - Jan 1996 · 3 yrs 1 mo
NEW YORK, NYNEW YORK, NY
Seized entrepreneurial opportunity to secure licenses for Russian medical/scientific technologies and launch commercialization efforts in the United States. Hired delegation of scientists to travel to Russia and identify technologies for potential U.S. commercialization. Successfully negotiated exclusive agreements with eminent Russian scientists. Coordinated patenting of various technologies with patent counsel, and Russian and American scientists.
Managed 15 simultaneous projects in ceramic coatings, bioremediation, agricultural products and polymeric resins.Raised over $5 million in capital from private investors; worked with Fortune 500 companies and government agencies that included DuPont, GE, 3M, NASA, DOD, and DOE, resulting in successful R&D joint ventures that saved company tens of millions in field study costs, and expedited time-to-market.
Worked directly with Russian Secretary of Science and Technology to initiate first government-sanctioned technology-transfer fund. Appeared on nationally televised documentary on technology transfer in Uzbekistan at the invitation of the Uzbekistan government.Established and managed relationships with scientific advisory boards at six major universities in the United States.
https://www.linkedin.com/in/andrew-braverman-5365aa4/
Keith Duffy
ExperienceExperience
Xeriant, Inc. logo
CEOCEO
Xeriant, Inc.Xeriant, Inc.
Oct 2018 - Present · 5 yrs 4 mosOct 2018 - Present · 5 yrs 4 mos
Boca Raton, Florida, United StatesBoca Raton, Florida, United States
Xeriant is a technology holding company focused on acquiring, developing and commercializing revolutionary, eco-friendly technologies with applications in aerospace, including innovative aircraft concepts targeting emerging opportunities with the aviation industry.Xeriant is a technology holding company focused on acquiring, developing and commercializing revolutionary, eco-friendly technologies with applications in aerospace, including innovative aircraft concepts targeting emerging opportunities with the aviation industry.…see more
CEOCEO
Currency Tracking TechnologiesCurrency Tracking Technologies
Jan 2017 - Present · 7 yrs 1 moJan 2017 - Present · 7 yrs 1 mo
Boynton Beach, FLBoynton Beach, FL
Currency Tracking Technologies develops proprietary software applications and systems for recording and managing information on U.S. currency to enhance the capabilities of law enforcement agencies and the intelligence community in detecting or solving crime.Currency Tracking Technologies develops proprietary software applications and systems for recording and managing information on U.S. currency to enhance the capabilities of law enforcement agencies and the intelligence community in detecting or solving crime.…see more
President/CEOPresident/CEO
AEGEA Entertainment, LLCAEGEA Entertainment, LLC
Jan 2012 - Present · 12 yrs 1 moJan 2012 - Present · 12 yrs 1 mo
North Palm Beach, FLNorth Palm Beach, FL
AEGEA is a planned city of entertainment and the arts in Florida.
https://www.linkedin.com/in/keith-duffy-4002ab1a/
Recent XERI News
- Xeriant Completes Critical Internal Fire Testing on NEXBOARD™ and Advances to Third-Party Certification Phase • GlobeNewswire Inc. • 04/13/2026 12:05:00 PM
- Xeriant Receives U.S. Patent Notice Allowance for its Breakthrough Fire-Resistant Composite Technology • GlobeNewswire Inc. • 04/02/2026 12:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:35:10 PM
- “Trump Homes” Ignite a New Housing Trade • GlobeNewswire Inc. • 02/04/2026 02:35:49 PM
- Building Affordability: How Innovative Public Companies Are Answering Trump’s Call to Fix America’s Housing Crisis • GlobeNewswire Inc. • 01/14/2026 01:45:00 PM
- Morning Market Pulse: AI, Autonomy, and National Security Drive the Narrative at the Open • GlobeNewswire Inc. • 01/06/2026 02:52:32 PM
- Morning Market Brief: Defense, Drones, and Space Capital- Execution Stories Drive Attention • GlobeNewswire Inc. • 01/05/2026 01:52:04 PM
- Xeriant Wishes Shareholders a Joyous Holiday Season and Banner 2026 • GlobeNewswire Inc. • 12/30/2025 01:05:00 PM
- Morning Market Pulse: Defense-to-Data Bets, Capital Raises, and AI-Powered Platforms Shape the Open • GlobeNewswire Inc. • 12/29/2025 02:35:06 PM
- IBN Initiates Coverage of Xeriant, Inc. • GlobeNewswire Inc. • 12/17/2025 01:30:00 PM
- Platforms, Proof, and Momentum • GlobeNewswire Inc. • 12/16/2025 02:45:19 PM
- Defense, Disruption & The New Industrial Base • GlobeNewswire Inc. • 12/10/2025 02:53:06 PM
- Architectural Transformation, Not Add-Ons • GlobeNewswire Inc. • 12/08/2025 02:49:16 PM
- Xeriant’s Strategic Pivot Positions Company for High-Velocity Future • GlobeNewswire Inc. • 11/28/2025 02:52:03 PM
- Xeriant Elevates Holt to Lead Factor X as Company Builds a Skunk Works–Style Innovation Engine • GlobeNewswire Inc. • 11/26/2025 03:22:43 PM
- Xeriant Appoints Brig. Gen. (Ret.) Blaine D. Holt President of Factor X Research Group • GlobeNewswire Inc. • 11/26/2025 01:05:00 PM
- Brig. Gen. (Ret.) Blaine D. Holt Broadens Role at Xeriant • GlobeNewswire Inc. • 11/25/2025 01:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/19/2025 09:05:55 PM
- Xeriant Proceeds Toward NEXBOARD™ Certification After Successful Internal Testing of Last Production Run • GlobeNewswire Inc. • 11/17/2025 02:05:00 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2025 09:15:48 PM
- Xeriant Reduces Debt and Reaches Amicable Settlement with Auctus Fund • GlobeNewswire Inc. • 11/13/2025 04:32:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 10:10:46 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/02/2025 08:44:06 PM
- Xeriant Initiates Certification Process with September Production of NEXBOARD Panels • GlobeNewswire Inc. • 09/30/2025 12:05:00 PM
